Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1985 Sep;61(719):773–778. doi: 10.1136/pgmj.61.719.773

The effects of treatment on target organ damage in hypertensive disease.

J Lowenstein
PMCID: PMC2418377  PMID: 2932687

Full text

PDF
773

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azar S., Tobian L., Johnson M. A. Glomerular, efferent arteriolar, peritubular capillary, and tubular pressures in hypertension. Am J Physiol. 1974 Nov;227(5):1045–1050. doi: 10.1152/ajplegacy.1974.227.5.1045. [DOI] [PubMed] [Google Scholar]
  2. BYROM F. B. The pathogenesis of hypertensive encephalopathy and its relation to the malignant phase of hypertension; experimental evidence from the hypertensive rat. Lancet. 1954 Jul 31;267(6831):201–211. doi: 10.1016/s0140-6736(54)91821-8. [DOI] [PubMed] [Google Scholar]
  3. Ballantyne D., Ballantyne F. C. Thiazides, beta blockers and lipoproteins. Postgrad Med J. 1983 Aug;59(694):483–488. doi: 10.1136/pgmj.59.694.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. ENOS W. F., Jr, BEYER J. C., HOLMES R. H. Pathogenesis of coronary disease in American soldiers killed in Korea. J Am Med Assoc. 1955 Jul 16;158(11):912–914. doi: 10.1001/jama.1955.02960110018005. [DOI] [PubMed] [Google Scholar]
  5. FEIGIN I., PROSE P. Hypertensive fibrinoid arteritis of the brain and gross cerebral hemorrhage: a form of "hyalinosis". Arch Neurol. 1959 Jul;1:98–110. doi: 10.1001/archneur.1959.03840010100012. [DOI] [PubMed] [Google Scholar]
  6. Farrar J. K., Jones J. V., Graham D. I., Strandgaard S., MacKenzie E. T. Evidence against cerebral vasospasm during acutely induced hypertension. Brain Res. 1976 Mar 5;104(1):176–180. doi: 10.1016/0006-8993(76)90661-2. [DOI] [PubMed] [Google Scholar]
  7. Fisher C. M. The arterial lesions underlying lacunes. Acta Neuropathol. 1968 Dec 18;12(1):1–15. doi: 10.1007/BF00685305. [DOI] [PubMed] [Google Scholar]
  8. Goldman A. I., Steele B. W., Schnaper H. W., Fitz A. E., Frohlich E. D., Perry H. M., Jr Serum lipoprotein levels during chlorthalidone therapy. A Veterans Administration-National Heart, Lung, and Blood Institute cooperative study on antihypertensive therapy: mild hypertension. JAMA. 1980 Oct 10;244(15):1691–1695. doi: 10.1001/jama.244.15.1691. [DOI] [PubMed] [Google Scholar]
  9. Gudbrandsson T., Hansson L., Herlitz H., Andrén L. Malignant hypertension--improving prognosis in a rare disease. Acta Med Scand. 1979;206(6):495–499. doi: 10.1111/j.0954-6820.1979.tb13553.x. [DOI] [PubMed] [Google Scholar]
  10. Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am J Med. 1980 Nov;69(5):725–732. doi: 10.1016/0002-9343(80)90438-6. [DOI] [PubMed] [Google Scholar]
  11. Jones D. B. Arterial and glomerular lesions associated with severe hypertension. Light and electron microscopic studies. Lab Invest. 1974 Oct;31(4):303–313. [PubMed] [Google Scholar]
  12. Koch K. M., Aynedjian H. S., Bank N. Effect of acute hypertension on sodium reabsorption by the proximal tubule. J Clin Invest. 1968 Jul;47(7):1696–1709. doi: 10.1172/JCI105860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Leren P., Foss P. O., Helgeland A., Hjermann I., Holme I., Lund-Larsen P. G. Effect of propranolol and prazosin on blood lipids. The Oslo Study. Lancet. 1980 Jul 5;2(8184):4–6. doi: 10.1016/s0140-6736(80)92888-3. [DOI] [PubMed] [Google Scholar]
  14. Lowenstein J., Beranbaum E. R., Chasis H., Baldwin D. S. Intrarenal pressure and exaggerated natriuresis in essential hypertension. Clin Sci. 1970 Mar;38(3):359–374. doi: 10.1042/cs0380359. [DOI] [PubMed] [Google Scholar]
  15. Lundin S. A., Hallbäck-Nordlander M. I. Regression of structural cardiovascular changes by antihypertensive therapy in spontaneously hypertensive rats. J Hypertens. 1984 Feb;2(1):11–18. doi: 10.1097/00004872-198402000-00003. [DOI] [PubMed] [Google Scholar]
  16. Strandgaard S., MacKenzie E. T., Sengupta D., Rowan J. O., Lassen N. A., Harper A. M. Upper limit of autoregulation of cerebral blood flow in the baboon. Circ Res. 1974 Apr;34(4):435–440. doi: 10.1161/01.res.34.4.435. [DOI] [PubMed] [Google Scholar]
  17. Waal-Manning H. J., Simpson F. O. Beta-blockers and lipid metabolism. Br Med J. 1977 Sep 10;2(6088):705–705. doi: 10.1136/bmj.2.6088.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wollam G. L., Hall W. D., Porter V. D., Douglas M. B., Unger D. J., Blumenstein B. A., Cotsonis G. A., Knudtson M. L., Felner J. M., Schlant R. C. Time course of regression of left ventricular hypertrophy in treated hypertensive patients. Am J Med. 1983 Sep 26;75(3A):100–110. doi: 10.1016/0002-9343(83)90126-2. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES